![Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.6b00006/asset/images/large/id-2016-000067_0007.jpeg)
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases
![Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.6b00006/asset/images/large/id-2016-000067_0005.jpeg)
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases
![Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.6b00006/asset/images/medium/id-2016-000067_0004.gif)